---
title: "Fangsheng Pharmaceutical (603998.SH) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603998.SH/norm.md"
symbol: "603998.SH"
name: "Fangsheng Pharmaceutical"
parent: "https://longbridge.com/en/quote/603998.SH.md"
datetime: "2026-05-20T21:16:24.557Z"
locales:
  - [en](https://longbridge.com/en/quote/603998.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603998.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603998.SH/norm.md)
---

# Fangsheng Pharmaceutical (603998.SH) — Financial Reports

## Income Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.2000 | 0.0883 | 0.2194 | 0.1898 | 0.2000 |
| ROE | 20.52% | 9.01% | 23.93% | 19.60% | 21.47% |
| Revenue | 462.77M | 493.13M | 419.07M | 416.17M | 418.08M |
| Net income | 88.39M | 38.10M | 99.04M | 80.98M | 88.26M |
| Operating income | 105.03M | 49.55M | 96.94M | 70.34M | 87.77M |
| Gross margin | 75.33% | 72.30% | 73.40% | 69.91% | 70.50% |
| Net margin | 19.10% | 7.73% | 23.63% | 19.46% | 21.11% |
| Profit quality | 130.99% | 31.02% | 101.63% | 65.40% | 400.30% |

## Balance Sheet (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 3.06B | 3.06B | 3.03B | 3.06B | 3.15B |
| Leverage | 1.66 | 1.70 | 1.73 | 1.78 | 1.79 |
| BVPS | 3.95 | 3.90 | 3.81 | 3.73 | 3.79 |
| Turnover | 0.5773 | 0.5525 | 0.5327 | 0.5416 | 0.5488 |
| Cash & STI | 254.24M | 276.25M | 220.09M | 145.87M | 187.23M |
| Inv & Rec | 350.59M | 338.71M | 358.28M | 383.44M | 386.40M |
| LT assets | 1.14B | 1.14B | 1.13B | 1.11B | 1.12B |
| Net debt | 151.00M | 155.78M | 312.91M | 395.77M | 395.02M |

## Cash Flow Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 80.19M | 159.76M | 95.39M | 107.56M | 21.93M |
| Investing CF | -53.40M | 30.09M | 38.23M | 12.18M | 1.21M |
| Financing CF | -83.90M | -90.98M | -78.89M | -177.89M | -146.35M |
| Free CF | 17.08M | 181.06M | -35.38M | 77.16M | 22.31M |
| OCF coverage | 28.09% | 90.58% | 90.27% | 31.95% | 6.84% |
| Repaid & issued | 170.00M | 30.00M | 4.00M | 174.40M | 155.00M |
| CapEx | -22.14M | -39.01M | -16.21M | -29.80M | -17.50M |

## Distribution Plan

**Dividend Yield**: 4.84

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.15CNY | 2026-01-15 | 2026-01-16 | 2026-01-16 |
| Cash Dividend: 
0.15CNY | 2025-09-17 | 2025-09-18 | 2025-09-18 |
| Cash Dividend: 
0.2CNY | 2025-06-06 | 2025-06-09 | 2025-06-09 |